Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L. Bolton, Dean F. Bajorin, Ryan Ptashkin et al.|Nature Genetics|2020Cited by 739
Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, William G. Wierda, Michael J. Keating et al.|New England Journal of Medicine|2019Cited by 502
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I. Hsu, Margaret A. Goodell, Tajhal Dayaram et al.|Cell stem cell|2018Cited by 423
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomicsKiyomi Morita, Koichi Takahashi, Latasha Little et al.|Nature Communications|2020Cited by 383
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D. DiNardo, Hagop M. Kantarjian, Curtis A. Lachowiez et al.|Journal of Clinical Oncology|2021Cited by 333